CVRx, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CVRx, Inc. on June 8, 2023, covering events occurring on June 5, 2023. The filing primarily reports the results of the Company's 2023 Annual Meeting of Stockholders and announces upcoming investor presentations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes and Voting Results
The following matters were submitted to a vote at the Annual Meeting:
- Proposal 1: Election of Directors. Two Class II nominees were elected to serve until the 2026 annual meeting:
- Kevin Hykes: 12,368,856 votes For; 617,120 votes Withheld; 5,809,856 Broker Non-Votes.
- Joseph Slattery: 11,896,881 votes For; 1,089,095 votes Withheld; 5,809,856 Broker Non-Votes.
- Proposal 2: Ratification of Auditors. Stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Votes For: 18,785,665
- Votes Against: 641
- Votes Abstain: 9,526
Guidance, Outlook, and Management Commentary
Under Item 7.01, the Company disclosed its intent to present materials at the 43rd Annual William Blair Growth Stock Conference on June 8, 2023. The presentation materials are included as Exhibit 99.1. The Company explicitly stated that this information is not "filed" with the SEC for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific content of the investor presentation materials attached as Exhibit 99.1 for updated business outlook or clinical trial data.
- Confirm the tenure of the newly elected directors (Kevin Hykes and Joseph Slattery) through the 2026 annual meeting.
- Review the Company's subsequent filings for the audited financial statements prepared by Grant Thornton LLP for the fiscal year ending December 31, 2023.